Related Experiment Video

Updated: Mar 26, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.4K

Inhibitor of growth-4 is a potential target for cancer therapy

Shuping Yuan1,2, Jianhua Jin1, Juanjuan Shi3

  • 1Department of Oncology, Affiliated Wujin People's Hospital, Jiangsu University, Changzhou, 212017, People's Republic of China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|January 25, 2016
PubMed

Insights

Inhibitor of growth-4 (ING-4) is a tumor suppressor that halts cancer progression and enhances treatment sensitivity. Research highlights its potential for gene therapy in various cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The inhibitor of growth (ING) family, including ING-4, comprises type II tumor suppressor genes.
  • ING-4 plays a crucial role in inhibiting tumor growth, invasion, and metastasis through various signaling pathways.
  • Loss of ING-4 is a common event in many cancer types, suggesting its significance in tumorigenesis.

Purpose of the Study:

  • To review recent advancements in understanding how ING-4 regulates tumorigenesis.
  • To explore the potential of ING-4 in cancer gene therapy.
  • To consolidate current knowledge on ING-4's function as a tumor suppressor.

Main Methods:

  • Literature review of recent research on ING-4 and cancer.
  • Analysis of signaling pathways regulated by ING-4.
  • Evaluation of ING-4's role in cancer progression and treatment response.

Main Results:

  • ING-4 demonstrates potent tumor suppressor activities, inhibiting key cancer hallmarks.
  • ING-4 enhances the sensitivity of cancer cells to chemotherapy and radiotherapy.
  • Evidence suggests ING-4's therapeutic potential in gene therapy strategies.

Conclusions:

  • ING-4 is a critical tumor suppressor with multifaceted roles in cancer biology.
  • Restoring or utilizing ING-4 function presents a promising avenue for cancer treatment.
  • Further research into ING-4 mechanisms can unlock new therapeutic applications for cancer patients.
Keywords:
Cell proliferationDNA repairING4NFκBp53

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.7K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.0K